Gil Hakim
2017
In 2017, Gil Hakim earned a total compensation of $1.3M as Former President at UroGen Pharma Ltd., a 219% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $114,242 |
|---|---|
| Option Awards | $778,733 |
| Salary | $390,406 |
| Other | $60,164 |
| Total | $1,343,545 |
Hakim received $778.7K in option awards, accounting for 58% of the total pay in 2017.
Hakim also received $114.2K in non-equity incentive plan, $390.4K in salary and $60.2K in other compensation.
Rankings
In 2017, Gil Hakim's compensation ranked 7,548th out of 14,666 executives tracked by ExecPay. In other words, Hakim earned more than 48.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,548 out of 14,666 | 49th |
Division Manufacturing | 2,825 out of 5,772 | 51st |
Major group Chemicals And Allied Products | 916 out of 2,075 | 56th |
Industry group Drugs | 714 out of 1,731 | 59th |
Industry Pharmaceutical Preparations | 556 out of 1,333 | 58th |
Source: SEC filing on April 26, 2019.
Hakim's colleagues
We found three more compensation records of executives who worked with Gil Hakim at UroGen Pharma Ltd. in 2017.